Suppr超能文献

镰状细胞病的骨髓移植:我们从这里走向何方?

Bone marrow transplantation for sickle cell disease: where do we go from here?

作者信息

Walters M C

机构信息

Fred Hutchinson Cancer Research Center and the Department of Pediatrics, University of Washington School of Medicine, Seattle, USA.

出版信息

J Pediatr Hematol Oncol. 1999 Nov-Dec;21(6):467-74. doi: 10.1097/00043426-199911000-00005.

Abstract

Bone marrow transplantation has curative potential for patients who have sickle cell disease. However, concerns about short-term and long-term toxicity, lack of suitable stem cell donors, and limited access to this treatment currently make it an infrequently utilized treatment for sickle cell disease. The current results of bone marrow transplantation for sickle cell disease and barriers to wider application are reviewed. Strategies that might lead to broader availability and reduced toxicity of bone marrow transplantation are discussed.

摘要

骨髓移植对患有镰状细胞病的患者具有治愈潜力。然而,对短期和长期毒性的担忧、缺乏合适的干细胞供体以及目前获得这种治疗的机会有限,使得它目前很少用于镰状细胞病的治疗。本文综述了镰状细胞病骨髓移植的当前结果以及更广泛应用的障碍。还讨论了可能导致骨髓移植更广泛可用和毒性降低的策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验